Publications by authors named "Harry J Long"

Claim this Profile
A
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors.
Andrea E Wahner Hendrickson, Michael E Menefee, Lynn C Hartmann, Harry J Long, Donald W Northfelt

Clin Cancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.
Leigh G Seamon, James J Java, Bradley J Monk, Richard T Penson, Jubilee Brown, Harry J Long

Br J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study.
Krishnansu S Tewari, Michael W Sill, Bradley J Monk, Richard T Penson, Harry J Long

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Richard T Penson, Helen Q Huang, Lari B Wenzel, Bradley J Monk, Sharon Stockman, Harry J Long

Lancet Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.
Dana M Chase, James Kauderer, Lari Wenzel, Lois Ramondetta, David Cella, Harry J Long

Int J Gynecol Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.
Evanthia Galanis, Pamela J Atherton, Matthew J Maurer, Keith L Knutson, Sean C Dowdy, Harry J Long

Cancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival with bevacizumab in advanced cervical cancer.
Krishnansu S Tewari, Michael W Sill, Harry J Long, Richard T Penson, Helen Huang

N Engl J Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
Tina A Ayeni, Jamie N Bakkum-Gamez, Andrea Mariani, Michaela E McGree, Amy L Weaver, Harry J Long

Gynecol Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
Dana M Chase, Helen Q Huang, Lari Wenzel, David Cella, Richard McQuellon, Harry J Long

Gynecol Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature.
Mariam M Alhilli, Harry J Long, Karl C Podratz, Jamie N Bakkum-Gamez

J Obstet Gynaecol Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual presentation of breast cancer in a very young woman.
Nicole P Sandhu, Harry J Long, Kiley J Johnson, Amy C Degnim

BMJ Case Rep· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.
Warner K Huh, Michael W Sill, Kathleen M Darcy, Kevin M Elias, James S Hoffman, Harry J Long

Gynecol Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.
Evanthia Galanis, Lynn C Hartmann, William A Cliby, Harry J Long, Prema P Peethambaram

Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.
David H Moore, Chunqiao Tian, Bradley J Monk, Harry J Long, George A Omura

Gynecol Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
Howard D Homesley, Virginia Filiaci, Susan K Gibbons, Harry J Long, David Cella

Gynecol Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies.
Steven C Plaxe, Sandra E Brooks, Chunquiao Tian, Jeffrey D Bloss, David H Moore, Harry J Long

Am J Obstet Gynecol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention, diagnosis, and treatment of cervical cancer.
Harry J Long, Nadia N I Laack, Bobbie S Gostout

Mayo Clin Proc· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of metastatic cervical cancer: review of the literature.
Harry J Long

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
Giovanni D Aletti, Harry J Long, Karl C Podratz, William A Cliby

Gynecol Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
Harry J Long, Robert A Nelimark, Karl C Podratz, Vera Suman, Gary L Keeney

Gynecol Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
Harry J Long, Bradley J Monk, Helen Q Huang, Edward C Grendys, D Scott McMeekin

Gynecol Oncol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
Hedvig Hricak, Constantine Gatsonis, Dennis S Chi, Marco A Amendola, Kathy Brandt, Harry J Long

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study.
Harry J Long, John A Blessing, Joel Sorosky

Gynecol Oncol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183.
Marco A Amendola, Hedvig Hricak, Donald G Mitchell, Bradley Snyder, Dennis S Chi, Harry J Long

J Clin Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
Harry J Long, Brian N Bundy, Edward C Grendys, Jo Ann Benda, D Scott McMeekin

J Clin Oncol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis